CLINICAL TRIALS BY STATE

Clinical Trials in Vermont

12+ recruiting studies in Vermont, updated in real time and displayed in plain English.

BROWSE BY CONDITION IN VERMONT

Bladder CancerBrain Tumor / GliomaBreast CancerCervical CancerColorectal CancerEndometrial / Uterine CancerHead & Neck CancerKidney / Renal Cell CarcinomaLeukemia (AML)Leukemia (CLL)Liver / Hepatocellular CarcinomaLung Cancer (NSCLC)Lung Cancer (SCLC)Lymphoma (Non-Hodgkin)MelanomaMultiple MyelomaOvarian CancerPancreatic Cancer

RECRUITING TRIALS IN VERMONT

RECRUITINGPhase 3

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

NCT05923073 · Los Angeles, Cedars Sinai Medical Center
RECRUITINGPhase 3

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

NCT04031677 · Birmingham, University of Alabama at Birmingham Cancer Center
RECRUITINGPhase 3

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

NCT05879926 · Birmingham, University of Alabama at Birmingham Cancer Center
RECRUITINGNA

Transcranial Magnetic Stimulation in Veterans With PTSD

NCT07336251 · White River Junction, White River Junction VA Hospital
RECRUITINGPhase 3

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

NCT06677060 · Birmingham, Research Site
RECRUITINGPhase 3

Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula

NCT06807437 · Birmingham, University of Alabama at Birmingham Cancer Center
RECRUITINGPhase 3

Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

NCT06463587 · Phoenix, Arizona Neuroscience Research, LLC
RECRUITINGPhase 2

MOHs Surgery and Short-Course Radiation Therapy With Structured Follow-Up for Head & Neck Squamous Cell Skin Cancer

NCT06998342 · Burlington, University of Vermont Medical Center
RECRUITINGNA

PRESERVE & CONNECT: Impact Study of the BPC

NCT06160050 · Hartford, University of Connecticut
RECRUITINGPhase 1

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

NCT06001788 · Gilbert, Banner MD Anderson Cancer Center
RECRUITINGPhase 3

A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT06290141 · Homewood, Alabama Neurology Associates- Site Number : 8400019
RECRUITINGPhase 3

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

NCT05125302 · Huntsville, Rehabilitation & Neurological Services /ID# 229969

COMMON QUESTIONS

How many clinical trials are available in Vermont?

There are currently 12+ recruiting clinical trials in Vermont listed on ClinicalTrials.gov. Clinicals AI makes these easier to browse with plain-language summaries and condition filters.

How do I join a clinical trial in Vermont?

Browse the listings above, review eligibility criteria, and submit a contact request. A study coordinator will follow up to discuss your eligibility and next steps.

Are clinical trials in Vermont free?

Most trials cover the investigational treatment and study-related visits at no cost. Some also offer compensation for time and travel. Confirm cost details with each trial coordinator.

What conditions have trials in Vermont?

Vermont hosts trials across cancer, cardiovascular disease, diabetes, neurological conditions, mental health, autoimmune disease, and rare conditions. Browse by condition using the links above.

OTHER STATES

CaliforniaNew YorkTexasFloridaPennsylvaniaOhioIllinoisMassachusettsMichiganWashington